Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Budesonide modified-release capsules.

D E Baker1

  • 1College of Pharmacy, Washington State University, Spokane, WA, USA.

Reviews in Gastroenterological Disorders
|July 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring and assessment of soil and forage molybdenum near an atmospheric source.

Environmental monitoring and assessment·2013
Same author

Force spectroscopy of hepatocytic extracellular matrix components.

Ultramicroscopy·2009
Same author

Esomeprazole magnesium (Nexium).

Reviews in gastroenterological disorders·2002
Same author

Pegylated interferons.

Reviews in gastroenterological disorders·2002
Same author

Tegaserod for the treatment of constipation-predominant irritable bowel syndrome.

Reviews in gastroenterological disorders·2002
Same author

Nateglinide therapy for type 2 diabetes mellitus.

The Annals of pharmacotherapy·2001
Same journal

Prevalence and risk factors of fecal incontinence in community-dwelling men.

Reviews in gastroenterological disorders·2010
Same journal

Diarrhea - novel transdermal patch vaccine to prevent travelers' diarrhea.

Reviews in gastroenterological disorders·2010
Same journal

Peptic ulcer bleeding following therapeutic endoscopy: a new indication for intravenous esomeprazole.

Reviews in gastroenterological disorders·2010
Same journal

Diarrhea--cryptosporidial diarrhea in patients with AIDS: impressive results with Rifaximin.

Reviews in gastroenterological disorders·2009
Same journal

Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.

Reviews in gastroenterological disorders·2009
Same journal

Antimicrobial resistance and eradication strategies for Helicobacter pylori.

Reviews in gastroenterological disorders·2009
See all related articles

Budesonide modified-release capsules effectively treat Crohn

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Internal Medicine

Background:

  • Crohn's disease is a chronic inflammatory bowel disease.
  • Budesonide is a corticosteroid with local anti-inflammatory effects.
  • Current therapies have limitations in efficacy and side effect profiles.

Purpose of the Study:

  • To evaluate the efficacy of budesonide modified-release capsules for Crohn's disease.
  • To compare budesonide with existing therapies like prednisolone and prednisone.
  • To assess the adverse reaction profile of budesonide compared to other corticosteroids.

Main Methods:

  • Treatment with budesonide modified-release capsules.
  • Assessment of therapeutic effectiveness in specific regions of the gastrointestinal tract (distal ileum, ileocecal region, ascending colon).

Related Experiment Videos

  • Comparison of budesonide with prednisolone and prednisone in active Crohn's disease.

    • Main Results:

    • Budesonide modified-release capsules are effective for Crohn's disease in the distal ileum, ileocecal region, and ascending colon.
    • Budesonide is less effective for extensive or left-sided colitis due to its local action.
    • Budesonide demonstrates comparable or lesser efficacy than prednisolone/prednisone but with fewer glucocorticoid-related adverse reactions.

    Conclusions:

    • Budesonide modified-release capsules offer an effective, localized treatment option for specific presentations of Crohn's disease.
    • The favorable side effect profile makes budesonide a valuable alternative to systemic corticosteroids for certain patients.
    • Treatment selection should consider disease location and the balance between efficacy and adverse effects.